- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06064188
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO)
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prenatal tracheal occlusion (TO) obstructs the normal egress of lung fluid during pulmonary development leading to increased lung tissue stretch, increased cell proliferation, and accelerated lung growth. European colleagues have developed foregut endoscopy and techniques to position and remove endoluminal tracheal balloons in utero. Recently, the Belgium group published summary results of FETO showing an improved survival in 175 patients with isolated left CDH from 24% to 49%.
The goal of this pilot study is to study the feasibility of implementing FETO therapy in the most severe group of fetuses with left CDH Observed/expected lung-to-head ratio < 25%(O/E LHR < 25%).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Timothy Crombleholme, MD
- Phone Number: 860-545-9830
- Email: tcrombleholme@connecticutchildrens.org
Study Contact Backup
- Name: James Santanelli, MS, MPH
- Phone Number: 860-837-5873
- Email: jsantanelli@connecticutchildrens.org
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- Recruiting
- Connecticut Children's Medical Center
-
Contact:
- Timothy Crombleholme, MD
- Phone Number: 860-545-9830
- Email: tcrombleholme@connecticutchildrens.org
-
Contact:
- James Santanelli, MS, MPH
- Phone Number: 8608375873
- Email: jsantanelli@connecticutchildrens.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women age 18 years and older, who are able to consent
- Singleton pregnancy
Exclusion Criteria:
- Pregnant women <18 years of age.
- Maternal contraindication to fetoscopic surgery or severe maternal medical condition in pregnancy
- Technical limitations precluding fetoscopic surgery
- Rubber latex allergy
- Preterm labor, cervix shortened (<15 mm at enrollment or within 24 hours of FETO balloon insertion procedure) or uterine anomaly strongly predisposing to preterm labor, placenta previa
- Psychosocial ineligibility, precluding consent
- Diaphragmatic hernia: right-sided or bilateral, major associated anomalies, isolated left-sided with the O/E LHR ≥ 25%
- Inability to remain at FETO site during time period of tracheal occlusion, delivery and postnatal care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fetoscopic Endoluminal Tracheal Occlusion (FETO)
An un-blinded non-randomized single arm pilot study of FETO in fetuses with congenital diaphragmatic hernia (CDH)
|
This study will position and remove an endoluminal tracheal balloon in utero (FETO) to study the feasibility of implementing FETO therapy in the most severe group of fetuses with left CDH and observed/expected length head ratio <25% (O/E LHR).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of neonatal survivors at time of discharge
Time Frame: Discharge from the hospital, an expected average of 12 weeks.
|
Percent of neonatal survivors at time of discharge
|
Discharge from the hospital, an expected average of 12 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prenatal increase in lung volume
Time Frame: 2 weeks (prenatally)
|
Lung volume after FETO procedure
|
2 weeks (prenatally)
|
Number of days of Postnatal mechanical ventilator support
Time Frame: First 28 days of postnatal life
|
mechanical ventilator support will be monitored and recorded in days of use
|
First 28 days of postnatal life
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Timothy Crombleholme, MD, Connecticut Children's Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-133 FETO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Diaphragmatic Hernias
-
Connecticut Children's Medical CenterRecruitingCongenital Diaphragmatic HerniasUnited States
-
University Hospital, Strasbourg, FranceTerminatedCongenital Diaphragmatic HerniasFrance
-
Zagazig UniversityCompleted
-
University of Sao Paulo General HospitalMinistry of Health, BrazilUnknownCongenital Diaphragmatic Hernia | Congenital AbnormalityBrazil
-
University Hospital, LilleAPEHDia, a french CDH patient association; Rare Disease Foundation, FranceNot yet recruitingCongenital Diaphragmatic Hernia
-
University of California, DavisNot yet recruitingCongenital Diaphragmatic HerniaUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingCongenital Diaphragmatic HerniaBelgium
-
McGill University Health Centre/Research Institute...RecruitingCongenital Diaphragmatic HerniaCanada
-
Johns Hopkins UniversityRecruitingCongenital Diaphragmatic HerniaUnited States
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedCongenital Diaphragmatic HerniaUnited States
Clinical Trials on Fetoscopic Endoluminal Tracheal Occlusion (FETO)
-
Alireza ShamshirsazNot yet recruitingCongenital Diaphragmatic HerniaUnited States
-
Children's Hospitals and Clinics of MinnesotaAllina Health SystemRecruiting
-
Connecticut Children's Medical CenterRecruitingCongenital Diaphragmatic HerniasUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingCongenital Diaphragmatic HerniaBelgium
-
University of Colorado, DenverRecruiting
-
Children's Hospital Medical Center, CincinnatiRecruitingCongenital Diaphragmatic Hernia | Pulmonary Hypoplasia | Pulmonary; HypertensionUnited States
-
Hanmin LeeRecruitingCongenital Diaphragmatic HerniaUnited States
-
University Hospital, GasthuisbergThe University of Texas Health Science Center, Houston; Baylor College of Medicine and other collaboratorsCompletedCongenital Diaphragmatic Hernia | Pulmonary Hypoplasia | Fetal SurgeryUnited Kingdom, Canada, United States, Belgium, Germany, Italy, France, Australia, Poland, Spain
-
University Hospital, BonnUniversitätsmedizin MannheimWithdrawnDiaphragmatic HerniaGermany
-
University of Sao Paulo General HospitalMinistry of Health, BrazilUnknownCongenital Diaphragmatic Hernia | Congenital AbnormalityBrazil